CARDIOVASCULAR SYSTEM - Comprehensive Integrated Study Notes
Sources
- Guyton and Hall Textbook of Medical Physiology (14th Ed, ISBN 9780443111013) - "Guyton"
- Robbins, Cotran & Kumar Pathologic Basis of Disease (10th Ed, ISBN 9780443264528) - "Robbins"
PART I: PHYSIOLOGY (GUYTON & HALL)
MODULE 1: CARDIAC MUSCLE PHYSIOLOGY
1.1 Core Anatomy of the Heart
The heart has three major muscle types:
- Atrial muscle - contractions pump blood into ventricles
- Ventricular muscle - provides the major pumping force
- Specialized excitatory/conductive fibers - contain few contractile fibrils; generate and conduct action potentials
Guyton, Ch. 9 (Block 1, line 3572)
1.2 Structural Features of Cardiac Muscle
| Feature | Detail |
|---|
| Striations | Present (actin + myosin, like skeletal muscle) |
| Cell arrangement | Latticework - fibers divide, recombine, and spread |
| Intercalated discs | Cell membranes between individual cells; contain gap junctions |
| Gap junctions | Allow rapid ion diffusion - cardiac muscle is a functional syncytium |
| Cell diameter | 10-15 μm (atrial/ventricular); 3-5 μm (nodal fibers) |
Functional Syncytium: Because ions diffuse rapidly through gap junctions, the action potential spreads throughout all connected fibers simultaneously. The atria form one syncytium; the ventricles form another. They are separated by the fibrous AV ring (annulus fibrosus).
Left Ventricular Torsion (Twist):
- Subepicardial fibers spiral leftward; subendocardial fibers spiral rightward (double helix)
- During systole: apex rotates counterclockwise, base rotates clockwise (viewed from apex)
- Creates a "wringing" motion - maximizes ejection efficiency
- At end-systole, LV acts as a loaded spring; untwists during diastole to facilitate rapid filling
Guyton, Ch. 9 (Block 1, lines 3575-3613)
1.3 Action Potential of Cardiac Muscle
VENTRICULAR MUSCLE ACTION POTENTIAL
Phase 0 (Rapid depolarization): Fast Na⁺ channels open → rapid Na⁺ influx → membrane potential
rises from -90 mV to +20 mV
Phase 1 (Early repolarization): Fast Na⁺ channels close; transient K⁺ outward current (Ito)
Phase 2 (Plateau): L-type Ca²⁺ channels open (slow Ca²⁺-Na⁺ channels) → sustained Ca²⁺ influx
balances K⁺ efflux → UNIQUE to cardiac muscle (lasts ~0.3 sec)
Phase 3 (Rapid repolarization): Ca²⁺ channels close; K⁺ channels (IKr, IKs) open →
K⁺ efflux repolarizes membrane
Phase 4 (Resting potential): -85 to -90 mV in ventricular cells
Key Difference from Skeletal Muscle: The plateau (Phase 2) is caused by slow Ca²⁺-Na⁺ channel activation and lasts ~0.3 seconds. This prolongs the action potential and prevents tetanic contraction (physiologically essential for pumping).
Refractory Period:
- Absolute refractory period: ~0.25-0.3 sec - virtually the entire period of systole
- Relative refractory period: ~0.05 sec after
- Prevents summation and tetanus - the heart MUST relax between beats to fill
1.4 Excitation-Contraction Coupling
Action potential → T-tubule depolarization
↓
L-type Ca²⁺ channels open on T-tubule membrane
↓
Ca²⁺ entry triggers Ca²⁺-induced Ca²⁺ release (CICR) from SR via ryanodine receptors (RyR2)
↓
Cytosolic Ca²⁺ rises 100-fold (10⁻⁷ → 10⁻⁵ mol/L)
↓
Ca²⁺ binds troponin C → conformational change in troponin-tropomyosin complex
↓
Tropomyosin moves off actin binding sites
↓
Myosin heads attach to actin (cross-bridge formation) → Power stroke → Contraction
↓
Relaxation: Ca²⁺ pumped back into SR (SERCA2a, stimulated by phospholamban)
+ expelled via Na⁺-Ca²⁺ exchanger (NCX)
Frank-Starling Law: Increased stretch of myocytes increases cross-bridge overlap, increasing force of contraction. More venous return → more stretch → stronger contraction → greater stroke volume. This is the intrinsic mechanism by which the heart pumps exactly the blood it receives.
MODULE 2: ELECTRICAL ACTIVITY OF THE HEART
2.1 Cardiac Conduction System
SA Node (pacemaker, 60-100 bpm)
↓ (internodal pathways + Bachmann's bundle)
AV Node (delay 0.1-0.12 sec)
↓
Bundle of His
↓ ↓
Left Bundle Branch Right Bundle Branch
↓ ↓
Left anterior/posterior Right ventricular
fascicles Purkinje fibers
↓
Ventricular muscle (endocardium → epicardium)
Guyton, Ch. 10 (Block 2, lines 341-370)
2.2 SA Node - The Natural Pacemaker
Location: Superior posterolateral wall of the right atrium, inferior and lateral to the superior vena cava opening. Size: 3 mm wide, 15 mm long, 1 mm thick.
Intrinsic rhythm: 60-100 bpm. Overrides all subsidiary pacemakers (AV node 40-60 bpm; Purkinje fibers 15-40 bpm) because it depolarizes fastest.
Mechanism of Automaticity (Pacemaker Potential):
- Resting membrane potential is only -55 to -60 mV (vs. -90 mV in ventricles) because the cell membrane is "leaky" to Na⁺ and Ca²⁺
- If (funny current): Hyperpolarization-activated Na⁺ current → slow spontaneous depolarization (Phase 4)
- When threshold (~-40 mV) is reached: L-type Ca²⁺ channels open → upstroke (no fast Na⁺ channels in nodal cells)
- Repolarization: K⁺ channels open
Autonomic Modulation:
| Effect | SNS (NE/Epi) | PNS (ACh) |
|---|
| Rate (chronotropy) | ↑ (If current ↑) | ↓ (IKACh ↑) |
| Contractility (inotropy) | ↑ | ↓ (atria only) |
| Conduction velocity | ↑ | ↓ (AV node) |
2.3 The Electrocardiogram (ECG)
| Wave/Interval | Origin | Normal Duration |
|---|
| P wave | Atrial depolarization | 0.06-0.12 sec |
| PR interval | Atrial depol + AV node delay | 0.12-0.20 sec |
| QRS complex | Ventricular depolarization | <0.12 sec |
| ST segment | Plateau of ventricular action potential | Isoelectric (no net current) |
| T wave | Ventricular repolarization | - |
| QT interval | Ventricular depolarization + repolarization | 0.35-0.44 sec |
High-Yield ECG Clues:
- ST elevation → acute transmural ischemia/STEMI (injury current from ischemic cells)
- ST depression → subendocardial ischemia / NSTEMI
- T wave inversion → myocardial ischemia, ventricular hypertrophy
- Wide QRS (>0.12 sec) → bundle branch block, ventricular rhythm
- Prolonged PR → first-degree AV block
- Delta wave + short PR → Wolff-Parkinson-White (accessory pathway)
MODULE 3: THE CARDIAC CYCLE
Guyton, Ch. 9 (Block 1, lines 3707-3727)
3.1 Phases of the Cardiac Cycle (Heart Rate 72 bpm = 0.83 sec/cycle)
DIASTOLE (≈0.5 sec total)
├── Isovolumetric relaxation: All valves closed; ventricle relaxes → pressure falls
├── Rapid ventricular filling (70%): Mitral/tricuspid open when LV pressure < LA pressure
├── Slow filling (diastasis): Blood trickles in
└── Atrial systole ("atrial kick"): Adds 20-30% of filling; ESSENTIAL at high heart rates
SYSTOLE (≈0.3 sec)
├── Isovolumetric contraction: All valves closed; LV pressure rises rapidly
├── Rapid ejection: Aortic valve opens when LV > Aortic pressure; fast SV ejected
└── Reduced ejection: Slower ejection; LV begins to relax
3.2 Pressure-Volume Relationships
| Parameter | Normal Value |
|---|
| End-diastolic volume (EDV) | ~120 mL |
| End-systolic volume (ESV) | ~50 mL |
| Stroke volume (SV) | ~70 mL (EDV - ESV) |
| Ejection fraction (EF) | ~60% (SV/EDV × 100) |
| Cardiac output (CO) | ~5 L/min (HR × SV) |
Heart Sounds:
- S1 ("lub"): Closure of mitral + tricuspid valves at start of systole
- S2 ("dub"): Closure of aortic + pulmonary valves at end of systole
- S3 (ventricular gallop): Rapid ventricular filling; normal in young; pathological in heart failure
- S4 (atrial gallop): Atrial contraction against stiff ventricle; seen in LVH, diastolic dysfunction
Effect of Increased Heart Rate: At very high HR, diastole shortens disproportionately → incomplete filling → reduced CO. This is why tachyarrhythmias can cause hemodynamic compromise.
MODULE 4: HEMODYNAMICS AND CARDIAC OUTPUT
4.1 Key Hemodynamic Equations
| Parameter | Formula | Normal |
|---|
| Cardiac Output | CO = HR × SV | 4-8 L/min |
| Cardiac Index | CI = CO / BSA | 2.5-4 L/min/m² |
| Mean Arterial Pressure | MAP = DBP + 1/3(PP) | 70-100 mmHg |
| Pulse Pressure | PP = SBP - DBP | ~40 mmHg |
| Total Peripheral Resistance | TPR = MAP / CO | ~1200 dyne·sec/cm⁵ |
| Ohm's Law | Flow = ΔP / R | - |
| Poiseuille's Law | R = 8ηL / πr⁴ | Radius is dominant factor |
Key Insight (Poiseuille): Resistance varies inversely with the 4th power of the radius. Halving the vessel radius increases resistance 16-fold. This makes arteriolar caliber the most powerful regulator of blood flow.
4.2 Frank-Starling Mechanism and Venous Return
Guyton, Ch. 20 (Block 3, lines 379-414)
- Venous return is the primary controller of cardiac output under normal conditions
- The heart has a built-in mechanism to pump whatever blood arrives (Frank-Starling)
- Mean circulatory filling pressure (MCFP): ~7 mmHg - the pressure that drives venous return when the heart stops
- Cardiac output curve: CO rises as right atrial pressure increases (Starling mechanism)
- Venous return curve: VR falls as right atrial pressure increases (less pressure gradient)
- Equilibrium point: Intersection of CO and VR curves = actual cardiac output
Factors Increasing CO:
- Increased blood volume (↑ MCFP → ↑ venous return)
- Sympathetic stimulation (↑ contractility + ↑ HR)
- Exercise (muscle pump, ↓ resistance, ↑ metabolic vasodilation)
- Hyperthyroidism, AV fistulas, Paget's disease, anemia (high-output states)
MODULE 5: BLOOD PRESSURE REGULATION
5.1 Short-Term Regulation
Baroreceptor Reflex (Most Important):
↑ Arterial BP
↓
Carotid sinus + aortic arch baroreceptors (stretch) → ↑ afferent impulses to NTS (medulla)
↓
↑ Vagal tone → ↓ HR (negative chronotropy)
↓ Sympathetic tone → ↓ HR, ↓ contractility, ↓ vasomotor tone → vasodilation
↓
↓ CO + ↓ TPR → BP normalizes
- Responds within seconds; resets over days with sustained hypertension (explains why it doesn't cure chronic HTN)
Other Short-Term Mechanisms:
- Chemoreceptor reflex (peripheral: carotid + aortic bodies; central: medullary)
- CNS ischemic response (Cushing response: last resort - activated when ICP rises)
- Stress relaxation of vessels
5.2 Long-Term Regulation - Pressure-Natriuresis
↑ Arterial BP
↓
↑ Renal perfusion pressure
↓
↑ Urinary Na⁺ and water excretion (pressure-natriuresis)
↓
↓ Blood volume → ↓ CO → ↓ BP
This system is infinitely gain - the kidneys can always bring BP back to normal as long as they function. Hypertension requires either a kidney defect or excess hormonal influence on the kidneys.
RAAS Axis:
↓ Renal perfusion / ↓ Na⁺ delivery to macula densa / ↑ SNS
↓
Juxtaglomerular cells release RENIN
↓
Angiotensinogen → Angiotensin I (ACE, lung) → Angiotensin II
↓
• Vasoconstriction (AT1 receptor)
• Aldosterone release (↑ Na⁺ + H₂O retention)
• ADH release (↑ water retention)
• Sympathetic activation
• Cardiac/vascular hypertrophy (remodeling)
MODULE 6: CORONARY CIRCULATION
Guyton, Ch. (Block 3, lines 1017-1055)
6.1 Anatomy
- Left coronary artery (LCA): Divides into LAD (anterior wall, septum) + LCx (lateral wall)
- Right coronary artery (RCA): Supplies RA, RV, inferior LV, SA node (in 60%), AV node (in 85%)
- Normal coronary blood flow: ~250 mL/min = ~5% of cardiac output
- Coronary flow mainly occurs in diastole (systolic compression of intramyocardial vessels)
- Subendocardium is most vulnerable to ischemia (highest wall tension, lowest perfusion pressure)
6.2 Autoregulation and Control
| Mechanism | Effect |
|---|
| Metabolic autoregulation | Adenosine, CO₂, K⁺, H⁺ from ischemic tissue → vasodilation |
| Myogenic autoregulation | Vessel maintains flow despite pressure changes (50-150 mmHg range) |
| Endothelial NO | cGMP → vasodilation (blocked in atherosclerosis) |
| Sympathetic | Alpha → vasoconstriction; Beta₂ → vasodilation (metabolic effect dominates) |
Coronary Flow Reserve: The ratio of maximal vasodilated flow to resting flow (~4-5x). Critical stenosis (>70% lumen narrowing) impairs flow reserve, limiting response to exercise.
MODULE 7: MICROCIRCULATION AND LYMPHATICS
- Capillary exchange: Starling forces govern fluid movement
- Filtration forces: Capillary hydrostatic pressure (Pc) + interstitial oncotic pressure (πi)
- Reabsorption forces: Plasma oncotic pressure (πp) + interstitial hydrostatic pressure (Pi)
- Net filtration pressure = (Pc + πi) - (πp + Pi)
- Slightly more fluid filters than is reabsorbed → lymphatics return excess ~2-4 L/day
- Edema = filtration > reabsorption + lymphatic capacity
- Increased Pc (↑ venous pressure, heart failure)
- Decreased πp (hypoalbuminemia)
- Increased capillary permeability (inflammation)
- Lymphatic obstruction (lymphedema)
PART II: PATHOLOGY (ROBBINS & COTRAN)
MODULE 8: ATHEROSCLEROSIS
Robbins, Ch. 11 (Block 5, lines 2764-3058)
8.1 Definition and Epidemiology
Atherosclerosis is an intimal-based lesion composed of a fibrous cap and atheromatous (lipid-rich) core affecting elastic arteries (aorta, carotids) and large/medium muscular arteries (coronaries, iliacs).
- Responsible for ~50% of deaths in Western world
- Leading cause globally: coronary artery disease → MI, sudden death
- Death rate from CAD in Eastern Europe is 7-12x higher than Japan
8.2 Risk Factors
| Nonmodifiable (Constitutional) | Modifiable |
|---|
| Genetic variation / Family history | Hyperlipidemia (↑ LDL, ↓ HDL) |
| Increasing age | Hypertension |
| Male sex (premenopausal females protected by estrogen) | Cigarette smoking |
| Diabetes mellitus |
| Obesity / metabolic syndrome |
| C-reactive protein / inflammation markers |
| Homocysteinemia |
Most important independent risk factor: FAMILY HISTORY
8.3 Pathogenesis - Response-to-Injury Hypothesis
STEP 1: ENDOTHELIAL INJURY / DYSFUNCTION
• Risk factors (HTN, hyperlipidemia, smoking, diabetes) cause endothelial activation
• ↓ Nitric oxide production → vasoconstriction, platelet aggregation
• ↑ Permeability + ↑ adhesion molecule expression (VCAM-1, ICAM-1, E-selectin)
STEP 2: LIPID ACCUMULATION IN INTIMA
• LDL enters and becomes oxidized (oxLDL) in the intima
• oxLDL is proinflammatory and cytotoxic to endothelium/SMCs
• "Fatty streak" (earliest lesion): flat, lipid-filled macrophages (foam cells) in intima
→ Appears in aorta as early as age 10
STEP 3: MONOCYTE RECRUITMENT AND FOAM CELL FORMATION
• Monocytes adhere to EC, transmigrate into intima, differentiate to macrophages
• Macrophages take up oxLDL via scavenger receptors (SR-A, CD36) → FOAM CELLS
• Foam cells secrete cytokines (TNF, IL-1, IL-6) → amplify inflammation
STEP 4: SMC MIGRATION AND PROLIFERATION
• Growth factors (PDGF, FGF from platelets, macrophages) → SMC migration from media to intima
• SMCs produce ECM (collagen, proteoglycans) → fibrous cap formation
• SMC proliferation + ECM = the fibrous cap
STEP 5: PLAQUE EVOLUTION
• Fibrous plaque: Central lipid/necrotic core + fibrous cap (collagen, SMCs, T cells)
• Calcification, hemorrhage, necrosis → complex (advanced) plaque
8.4 Stable vs. Vulnerable (Unstable) Plaques
| Feature | Stable Plaque | Vulnerable Plaque |
|---|
| Fibrous cap | Thick | Thin |
| Lipid core | Small | Large |
| Inflammation | Minimal | Dense (macrophages, T cells) |
| MMPs | Low | High (degrade cap collagen) |
| Risk | Gradual stenosis | Rupture → thrombosis → ACS |
| Stenosis | Often >70% | Often <50% |
Key Insight: Most MIs occur from rupture of a plaque that did NOT cause critical stenosis (i.e., no prior angina). The "vulnerable plaque" concept explains why statin therapy reduces MI risk beyond just lowering cholesterol - it stabilizes plaque by reducing inflammation.
8.5 Complications of Atherosclerosis
- Plaque rupture → acute thrombosis → MI, stroke
- Plaque erosion (more common in women, diabetics) → thrombosis without rupture
- Calcification → stenosis
- Aneurysm formation (media ischemia from increased diffusion distance)
- Embolism from mural thrombus
MODULE 9: ISCHEMIC HEART DISEASE (IHD)
Robbins, Ch. 12 (Block 6, lines 1077-1469)
9.1 Definition and Overview
IHD = a group of related entities resulting from myocardial ischemia (imbalance between O₂ supply and demand). >90% caused by coronary atherosclerosis. Also called Coronary Artery Disease (CAD).
IHD is the single largest cause of mortality worldwide (>15% of global deaths, ~9 million/year in high-resource countries).
9.2 Clinical Presentations of IHD
CORONARY ATHEROSCLEROSIS (slow, decades-long progression)
↓
Plaque rupture / thrombosis
↓
┌────────────────────────────────────────────────────────┐
│ │
Stable Angina Unstable Angina Acute MI Sudden Cardiac
(>70% fixed (non-occlusive (complete Death
stenosis; mural thrombus; occlusion; (ventricular
exertional rest pain) necrosis) fibrillation)
chest pain)
└────────────────────────────────────────────────────────┘
↓
Chronic IHD / Heart Failure
9.3 Myocardial Infarction
Types:
| STEMI | NSTEMI |
|---|
| Transmural (full-thickness) | Subendocardial (partial) |
| Complete coronary occlusion | Incomplete or transient occlusion |
| ST elevation on ECG | ST depression / T-wave changes |
| Total occlusion thrombus | Mural (non-occlusive) thrombus |
| Higher early mortality | Often multivessel disease |
Most common locations:
- LAD territory (40-50%): Anterior wall + apex + anterior septum
- RCA territory (30-40%): Inferior + posterior LV
- LCx territory (15-20%): Lateral LV wall
Pathogenesis of Ischemic Cell Injury:
Ischemia → ↓ O₂ → ↓ Oxidative phosphorylation → ↓ ATP
→ Switch to anaerobic glycolysis → lactic acidosis
→ Na⁺/K⁺-ATPase failure → ↑ intracellular Na⁺, Ca²⁺, water
→ Cell swelling → membrane blebbing
>20-30 minutes of ischemia → IRREVERSIBLE INJURY (point of no return)
↓
Lysosomal enzyme release + Ca²⁺ overload → myocyte necrosis (coagulative necrosis)
9.4 Morphologic Evolution of MI
Robbins, Table 12.5 (Block 6, lines 1286-1288)
| Time | Gross | Light Microscope | Electron Microscope |
|---|
| 0-0.5 hr (reversible) | None | None | Mitochondrial swelling; glycogen loss; myofibril relaxation |
| 0.5-4 hr | None | Variable wavy fibers at border | Sarcolemmal disruption; mitochondrial densities |
| 4-12 hr | Dark mottling | Early coagulative necrosis; edema; hemorrhage | - |
| 12-24 hr | Dark mottling | Coagulative necrosis; pyknotic nuclei; hypereosinophilia; contraction band necrosis; neutrophil infiltrate | - |
| 1-3 days | Yellow-tan center with mottling | Loss of nuclei + striations; brisk neutrophil infiltrate | - |
| 3-7 days | Hyperemic border; central yellow-tan softening | Disintegration of dead fibers; macrophage infiltration | - |
| 1-3 weeks | Yellow-tan with fibrovascular border | Granulation tissue replacing dead myocytes | - |
| >2 months | White, firm scar | Fibrous scar; minimal cellularity | - |
Useful trick: TTC (triphenyl tetrazolium chloride) staining - intact myocardium stains brick-red; infarcted (LDH-depleted) tissue is pale/unstained. Useful for recognizing early MI at autopsy.
Reperfusion Injury: Restoring blood flow after ischemia paradoxically causes additional damage via:
- Reactive oxygen species (ROS) from re-energized cells + infiltrating neutrophils
- Calcium overload
- Mitochondrial permeability transition pore (mPTP) opening
- Manifests as contraction band necrosis (hypercontracted sarcomeres), arrhythmias
Cardiac Biomarkers:
| Marker | Rises | Peaks | Returns to Normal | Notes |
|---|
| Troponin I / T | 3-6 hrs | 12-24 hrs (TnI), 12-48 hrs (TnT) | 7-10 days | Gold standard; most sensitive/specific |
| CK-MB | 4-8 hrs | 24 hrs | 48-72 hrs | Used to detect reinfarction |
| Myoglobin | 1-4 hrs | 4-8 hrs | 24-48 hrs | First to rise; non-specific |
| LDH | 24 hrs | 3-6 days | 8-14 days | Historical; LDH1 > LDH2 flip |
9.5 Complications of MI
EARLY (within hours-days):
• Arrhythmias (most common cause of death in first hour) - VF
• Cardiogenic shock (large MI >40% LV)
• Pericarditis (fibrinous, 2-4 days post-MI) → Dressler's syndrome (autoimmune, weeks later)
EARLY-INTERMEDIATE (days-2 weeks):
• Cardiac rupture:
- Free wall rupture (1-3 days, 3-5 days most common) → hemopericardium → tamponade
- Septal rupture → VSD → acute left-to-right shunt
- Papillary muscle rupture → acute mitral regurgitation
→ All more common with FIRST MI, no prior infarction/scar
LATE (weeks-months):
• Ventricular aneurysm (mural - fibrous thin wall; contains thrombus)
• Mural thrombus (akinetic wall → stasis → emboli)
• Chronic heart failure (ischemic cardiomyopathy)
MODULE 10: HEART FAILURE
Robbins, Ch. 12 (Block 6, lines 635-774)
10.1 Definition
Heart failure = inability of the heart to pump blood to meet peripheral metabolic demands, or to do so only at elevated filling pressures. Affects >6.5 million Americans; ~400,000 deaths/year; 5-year mortality ~50%.
10.2 Compensatory Mechanisms (Initially Adaptive, Then Maladaptive)
Cardiac Injury / Overload
↓
1. Frank-Starling mechanism: ↑ EDV → ↑ stretch → ↑ contractile force
2. Neurohormonal activation:
• SNS: ↑ NE → ↑ HR + contractility + vasoconstriction
• RAAS: ↑ Angiotensin II + Aldosterone → Na⁺/water retention → ↑ preload
• ADH: ↑ water retention
• ANP/BNP: Counterregulatory (natriuresis, vasodilation) - elevated in CHF → useful biomarker
3. Cardiac hypertrophy and remodeling
↓
(Over time → maladaptive)
• Neurohormonal overdrive → fibrosis, apoptosis, further dysfunction
• Pathologic hypertrophy → myocyte disorganization, fibrosis
• Ventricular dilation → geometric disadvantage (↓ efficiency per Laplace's law)
↓
DECOMPENSATED HEART FAILURE
10.3 HFrEF vs. HFpEF
| Feature | HFrEF (EF ≤40%) | HFpEF (EF ≥50%) |
|---|
| Mechanism | Systolic dysfunction (↓ contractility) | Diastolic dysfunction (↓ compliance) |
| Pathology | Dilated, thin-walled ventricle | Hypertrophied, stiff ventricle |
| Cause | Post-MI, DCM, myocarditis | HTN, HCM, amyloidosis, aging |
| Demographics | Younger, male | Older, female, obese, diabetic |
| BNP | ↑↑ | ↑ (less) |
| Treatment | GDMT (ACEi, BB, MRA, SGLT2i) | Limited proven treatments |
10.4 Left-Sided Heart Failure
Robbins, Block 6, lines 711-747
Causes: Ischemic heart disease, hypertension, aortic/mitral valve disease, DCM
Morphology:
- LV dilation and hypertrophy (eccentric or concentric depending on etiology)
- LA dilation (pulmonary congestion)
- Lungs: edema, "brawny induration" (chronic congestion), hemosiderin-laden macrophages ("heart failure cells") in alveolar spaces
Clinical Features:
- Forward failure: ↓ CO → fatigue, weakness, ↓ exercise tolerance, renal hypoperfusion (prerenal azotemia), cool extremities
- Backward failure: ↑ pulmonary venous pressure → pulmonary edema → dyspnea, orthopnea, PND, crackles
10.5 Right-Sided Heart Failure
Cause: Most often from left-sided heart failure (↑ pulmonary pressure → RV overload); also pulmonary HTN, COPD ("cor pulmonale"), RV infarction
Morphology: RV dilation and hypertrophy; hepatic congestion ("nutmeg liver" → cardiac cirrhosis); splenomegaly; edema
Clinical Features (Backward failure):
- JVD (jugular venous distension)
- Peripheral pitting edema (dependent)
- Hepatomegaly, ascites
- Anorexia, nausea (bowel congestion)
MODULE 11: CARDIOMYOPATHIES
Robbins, Ch. 12 (Block 6, lines 1966-2215)
11.1 Classification and Comparison
| Feature | Dilated (DCM) | Hypertrophic (HCM) | Restrictive (RCM) |
|---|
| Ventricle | Dilated, thin wall | Hypertrophied (asymmetric septal), NOT dilated | Normal/slight hypertrophy; non-compliant |
| Dominant dysfunction | Systolic (↓ EF) | Diastolic (poor compliance ± outflow obstruction) | Diastolic (rigid wall) |
| Genetics | Cytoskeletal proteins (TTN, LMNA, dystrophin) - AD, 50% cases | Sarcomeric proteins (MYH7, MYBP-C) - AD with variable penetrance | Amyloid, sarcoid, hemochromatosis, Loeffler |
| Key mutation | Titin (TTN) truncations = 10-20% DCM | β-MHC (MYH7) + MYBP-C = 70-80% HCM | Varies by etiology |
| Echo | ↓ EF; dilated all 4 chambers | HOCM with SAM; asymmetric septal hypertrophy | ↓ diastolic filling; "sparkling" myocardium (amyloid) |
| Microscopy | Myocyte hypertrophy + atrophy; interstitial fibrosis; scattered lymphocytes | Myocardial disarray (disorganized bundles); interstitial fibrosis | Amyloid deposition; granulomas (sarcoid) |
| Major risk | Systolic heart failure; thromboemboli | Sudden cardiac death (young athletes); outflow obstruction | Progressive heart failure |
| Treatment | GDMT (same as HFrEF); ICD; transplant | Septal myectomy / alcohol ablation; Mavacamten (myosin inhibitor) | Treat underlying cause |
11.2 DCM - Key Points
- Progressive dilation + systolic dysfunction; ALL 4 chambers enlarged
- 50% familial (mutations in cytoskeletal proteins: titin, lamin A/C, dystrophin, desmin)
- Other causes: viral myocarditis (Coxsackie B), alcohol (direct toxicity + thiamine deficiency → beriberi), cobalt, chemotherapy (anthracyclines, trastuzumab), peripartum, HIV
- Microscopy: hypertrophied + atrophied fibers; interstitial/perivascular fibrosis; vacuolar change; no necrosis (unless from ischemia)
11.3 HCM - Key Points
- Prevalence 1 in 500 - most common genetic cardiovascular disease
- AD with variable penetrance; gain-of-function mutations in sarcomeric proteins → hypercontractility
- Classic: asymmetric septal hypertrophy + SAM (systolic anterior motion of mitral valve) → LVOTO
- Microscopy: "myocardial disarray" (cardinal feature - disorganized bundles, chaotic myocyte arrangement) + interstitial fibrosis
- Leading cause of sudden cardiac death in young athletes (arrhythmia from disarrayed myocytes)
- Novel therapy: Mavacamten - allosteric inhibitor of cardiac myosin ATPase (reduces hypercontractility)
MODULE 12: VALVULAR HEART DISEASE
Robbins, Ch. 12 (Block 6, lines 1591-1665)
12.1 Overview
| Type | Mechanism | Main Causes |
|---|
| Aortic stenosis | Calcification/leaflet fixation | Degenerative calcification (age >60); Bicuspid aortic valve (age 40-60); Rheumatic (rare in developed world) |
| Aortic regurgitation | Valve/aortic root failure | Aortic root dilation (HTN, aging, Marfan); Infective endocarditis; Bicuspid AV; Rheumatic |
| Mitral stenosis | Leaflet fusion/scarring | Rheumatic heart disease (most common cause worldwide) |
| Mitral regurgitation | Valve/subvalvular failure | Mitral valve prolapse (myxomatous degeneration - most common in US); Ischemic (papillary muscle dysfunction); Infective endocarditis; Rheumatic |
| Mitral valve prolapse | Myxomatous degeneration | Idiopathic (2-3% population); Marfan syndrome; Ehlers-Danlos |
12.2 Calcific Aortic Stenosis
Robbins, Block 6, lines 1618-1637
- Most common valvular disease requiring surgery in developed world
- Degenerative calcification of normally tricuspid valve (age >70) or congenitally bicuspid valve (age 40-60s)
- Pathogenesis similar to atherosclerosis: lipid deposition, macrophage/lymphocyte infiltration, fibrosis, calcification
- Symptoms (SAD triad): Syncope, Angina, Dyspnea (in order of increasing severity)
- Once symptomatic: median survival - syncope 3 years, angina 5 years, dyspnea/CHF 2 years
- Murmur: Systolic ejection murmur - harsh, crescendo-decrescendo, radiates to neck
12.3 Rheumatic Heart Disease
- Follows streptococcal pharyngitis by 2-4 weeks
- Autoimmune: molecular mimicry - anti-strep antibodies cross-react with cardiac antigens (M protein vs. cardiac myosin, valvular glycoproteins)
- Acute Rheumatic Fever (Jones Criteria):
- Major: Carditis, Polyarthritis, Chorea, Erythema marginatum, Subcutaneous nodules
- Minor: Fever, elevated CRP/ESR, prolonged PR interval
- Acute lesion: Aschoff bodies (granulomatous foci with fibrinoid necrosis, macrophages/Anitschkow cells "owl-eye" caterpillar cells, lymphocytes)
- Verrucous endocarditis: Small fibrinous vegetations along valve leaflet lines of closure
- Chronic: Fibrous thickening and fusion of leaflets + commissure fusion → mitral stenosis ("fish mouth" valve)
MODULE 13: HYPERTENSION AND HYPERTENSIVE HEART DISEASE
13.1 Hypertension
Definition: Sustained BP >130/80 mmHg (ACC/AHA 2017) - present in 1 billion people worldwide
| Type | Description | % |
|---|
| Primary (essential) | No identifiable cause; polygenic + environmental | 95% |
| Secondary | Identifiable cause | 5% |
Secondary HTN causes: Renal parenchymal disease, renovascular disease (renal artery stenosis), primary hyperaldosteronism (Conn's syndrome), pheochromocytoma, Cushing's syndrome, coarctation of aorta, OCP use
Pathogenesis of Primary HTN: Complex interaction of:
- Genetic factors (dozens of alleles; affects Na⁺ handling, RAAS, SNS)
- Increased Na⁺ retention → volume expansion (environmental: high-salt diet + genetic susceptibility)
- RAAS overactivation
- SNS overactivity
- Endothelial dysfunction (↓ NO, ↑ ET-1)
- Insulin resistance / metabolic syndrome
13.2 End-Organ Damage in Hypertension
| Organ | Pathology |
|---|
| Heart | Left ventricular hypertrophy (LVH) → diastolic dysfunction → HFpEF → dilated ischemic HF; ↑ risk sudden death; ↑ risk MI |
| Brain | Lacunar infarcts, hypertensive encephalopathy, intracerebral hemorrhage (Charcot-Bouchard microaneurysms in basal ganglia), vascular dementia |
| Kidney | Hypertensive nephrosclerosis: arteriolar thickening (hyaline arteriolosclerosis) → ↓ GFR; Malignant HTN: fibrinoid necrosis of arterioles ("flea-bitten kidney") |
| Eyes | Arteriovenous nicking, flame hemorrhages, cotton-wool spots, papilledema (malignant HTN) |
| Arteries | Accelerated atherosclerosis; aortic dissection |
13.3 Hypertensive Heart Disease
Concentric LV Hypertrophy = adaptation to sustained pressure overload (↑ afterload)
- Sarcomeres added in parallel → increased wall thickness without increase in cavity size
- Initially compensatory → maintains systolic function
- Over time → diastolic dysfunction (stiff ventricle) → HFpEF
- Eventually systolic dysfunction as decompensation occurs → HFrEF
Eccentric Hypertrophy = response to volume overload (e.g., aortic regurgitation, DCM)
- Sarcomeres added in series → cavity dilates + wall thins
MODULE 14: PERICARDIAL DISEASES
| Disease | Cause | Morphology | Clinical |
|---|
| Fibrinous pericarditis | Post-MI (Dressler's), uremia, radiation | "Bread-and-butter" surface; shaggy fibrin | Pleuritic chest pain; friction rub; Saddleback ST elevation |
| Serous pericarditis | Viral (Coxsackie, echovirus), SLE, RA | Pale yellow exudate; usually <30 mL | Mild chest pain; may have rub |
| Purulent/suppurative | Bacterial (Staph, Strep, Pneumo) | Turbid, thick exudate | Sepsis + chest pain |
| Hemorrhagic | TB, malignancy, trauma | Blood + fibrin | Tamponade risk |
| Cardiac Tamponade | Rapid effusion >200 mL | Compression of cardiac chambers | Beck's triad: hypotension, JVD, muffled heart sounds; pulsus paradoxus |
| Constrictive pericarditis | TB, post-viral, post-radiation | Fibrous, calcified pericardium | Mimics right heart failure; Kussmaul's sign |
MODULE 15: ANEURYSMS AND DISSECTION
Robbins, Ch. 11 (Block 5, lines 3061-3200)
15.1 Definitions
- True aneurysm: Involves all three layers (intima, media, adventitia); e.g., atherosclerotic AAA, ventricular aneurysm post-MI
- False aneurysm (pseudoaneurysm): Defect in wall → extravascular hematoma communicating with vessel; e.g., post-MI free-wall rupture contained by pericardium
- Dissection: Blood enters defect in wall and tunnels through media; does NOT require prior aneurysm
15.2 Abdominal Aortic Aneurysm (AAA)
- Most common location: Infrarenal aorta (between renal arteries and bifurcation)
- Risk factors: Male sex (5:1), age >50, smoking, HTN, atherosclerosis
- Size threshold for repair: ≥5.5 cm (risk of rupture increases exponentially)
- Morphology: Severe atherosclerosis with medial destruction; mural thrombus; fusiform or saccular
- Rupture risk: Abrupt onset tearing/ripping abdominal/back pain → hemorrhagic shock; mortality >80% if ruptured, ~5% for elective repair
15.3 Aortic Dissection
- Most common life-threatening aortic catastrophe
- Blood enters media through intimal tear → splits media longitudinally
- Main risk factor: HYPERTENSION (>90%)
- Also: Marfan syndrome (cystic medial degeneration → elastic fiber fragmentation), bicuspid AV, pregnancy, Ehlers-Danlos
- Stanford Classification:
- Type A: Involves ascending aorta (±descending) → emergency surgery
- Type B: Only descending aorta (distal to L subclavian) → medical management initially
- DeBakey Classification: Type I (entire aorta), Type II (ascending only), Type III (descending only)
- Clinical: Sudden severe "tearing" or "ripping" chest pain radiating to back/abdomen; asymmetric pulses and BP in arms; aortic regurgitation murmur (Type A)
- Complications: Cardiac tamponade (Type A), aortic regurgitation, coronary/brachiocephalic artery occlusion, spinal ischemia, renal/mesenteric ischemia
MODULE 16: VASCULITIS
Robbins, Ch. 11 (Block 5, lines 3246-3250)
16.1 Classification by Vessel Size
| Vasculitis | Vessel Size | Key Features | Classic Presentation |
|---|
| Giant Cell (Temporal) Arteritis | Large (temporal, ophthalmic, aorta) | Granulomatous; CD4+ T cells; giant cells; skip lesions | Age >50; headache, scalp tenderness, jaw claudication, visual loss; ↑ ESR |
| Takayasu Arteritis | Large (aorta + branches) | Granulomatous; "pulseless disease" | Age <40 (female); diminished pulses; limb claudication; visual disturbances |
| Polyarteritis Nodosa (PAN) | Medium (renal, hepatic, coronary) | Segmental necrotizing; NOT associated with ANCA; associated with HBV | Fever, weight loss; renal failure; hypertension; abdominal pain; mononeuritis multiplex |
| Kawasaki Disease | Medium (coronary arteries) | Necrotizing inflammation + aneurysm formation | <5 years old; fever >5 days; CRASH mnemonic; coronary aneurysms |
| Wegener's (GPA) | Small (respiratory + renal) | Granulomatous; c-ANCA (anti-PR3) | Sinusitis, hemoptysis, glomerulonephritis; "saddle-nose deformity" |
| Churg-Strauss (EGPA) | Small | Granulomatous + eosinophilic; p-ANCA (anti-MPO) | Asthma + eosinophilia + vasculitis; cardiac involvement in 50% |
| Microscopic Polyangiitis | Small (capillaries) | Non-granulomatous; p-ANCA | Pulmonary-renal syndrome |
| IgA Vasculitis (HSP) | Small (IgA deposits) | Immune complex mediated | Children; palpable purpura + arthritis + GI pain + nephritis |
MODULE 17: THROMBOSIS, EMBOLISM, AND INFARCTION
Robbins, Ch. 4 (Block 2, lines 296-570)
17.1 Virchow's Triad - Pathogenesis of Thrombosis
THROMBOSIS
↗ ↑ ↖
Endothelial Abnormal Blood flow
Injury blood flow abnormality
(exposure (stasis or (hypercoagulability)
of TF, turbulence)
collagen)
Arterial thrombosis: Plaque rupture → platelet-rich "white thrombus" (primary, then secondary)
Venous thrombosis (DVT): Stasis + hypercoagulability → fibrin-rich "red thrombus"
Hypercoagulable States:
| Inherited | Acquired |
|---|
| Factor V Leiden (most common; APC resistance) | Immobilization |
| Prothrombin G20210A | Post-surgery |
| AT-III deficiency | Malignancy (Trousseau's) |
| Protein C/S deficiency | Antiphospholipid syndrome |
| Pregnancy/OCP |
| HIT |
17.2 Embolism Types
| Type | Source | Key Complications |
|---|
| Pulmonary embolism | DVT (iliac, femoral, popliteal veins) | Sudden dyspnea/pleuritic pain; saddle embolus → sudden death; smaller → infarction (hemorrhagic wedge-shaped pleural-based) |
| Systemic arterial embolism | Cardiac thrombus (LV post-MI, LA in AF); atheroma | Limb ischemia, stroke, mesenteric ischemia, renal infarction |
| Fat embolism | Long bone fractures, liposuction | Petechiae, neurological symptoms, hypoxemia (>24 hr post-trauma) |
| Air embolism | Iatrogenic IV, decompression sickness | Gas lock in pulmonary arteries; "bends" (N₂ bubbles in joints, fat, CNS) |
| Amniotic fluid embolism | Labor/delivery | DIC + respiratory failure; enters maternal veins |
17.3 Shock
Robbins, Ch. 4 (Block 2, lines 651-756)
| Type | Mechanism | Hemodynamics | Examples |
|---|
| Cardiogenic | Pump failure | ↓ CO, ↑ SVR, ↑ PCWP | Massive MI, tamponade, massive PE |
| Hypovolemic | ↓ Blood/fluid volume | ↓ CO, ↑ SVR, ↓ CVP | Hemorrhage, burns, dehydration |
| Distributive (Septic) | Vasodilation + maldistribution | ↓ SVR, ↑/normal CO, ↑ cardiac demand | Sepsis, anaphylaxis, neurogenic |
| Obstructive | Outflow obstruction | ↓ CO, ↑ SVR | Massive PE, tension pneumothorax, tamponade |
Stages of Shock:
- Compensated/Reversible: SNS activation → tachycardia, vasoconstriction, pallor, ↑ ADH/RAAS → oliguria. BP maintained.
- Progressive: Tissue hypoxia → anaerobic metabolism → lactic acidosis → cell injury. Compensatory mechanisms fail.
- Irreversible: Widespread cell death; vital organ failure; DIC; MODS; death.
Septic Shock - Pathogenesis:
Infection (gram +/-, fungi) → pattern recognition (TLRs) → macrophage activation
↓
Cytokine storm: TNF-α, IL-1, IL-6, IL-12 → massive vasodilation + ↑ permeability
↓
• iNOS overactivation → excess NO → refractory vasodilation
• Endothelial activation → DIC
• Mitochondrial dysfunction → energy failure
• Multi-organ dysfunction syndrome (MODS)
MODULE 18: VASCULAR TUMORS
| Tumor | Origin | Behavior | Key Features |
|---|
| Hemangioma | Benign vascular | Benign | Most common benign tumor; capillary (skin) or cavernous (liver, brain) types; often regress in infancy |
| Pyogenic granuloma | Capillary hemangioma variant | Benign | Pedunculated lesion; bleeds easily; associated with trauma, pregnancy |
| Glomus tumor | Glomus body (AVS) | Benign | Painful subungual lesion; benign |
| Kaposi Sarcoma | Endothelial (HHV-8) | Intermediate/malignant | Associated with HIV/AIDS + HHV-8; spindle cell fascicles; slit-like vascular spaces |
| Angiosarcoma | Malignant endothelial | Malignant | Associated with: radiation, vinyl chloride (liver KS), chronic lymphedema (Stewart-Treves). Hemorrhagic nodules; poor prognosis |
| Hemangiopericytoma | Pericytes | Intermediate | Rare; "staghorn" vessels on histology |
PART III: INTEGRATED CLINICAL CORRELATIONS
FLOWCHART A: Chest Pain - Differential Diagnosis Approach
ACUTE CHEST PAIN
↓
ECG ← → 12-lead ECG + Troponin + CXR
↓
┌─────────────────────┬───────────────────────┐
ST Elevation Normal ECG + Pleuritic pain
(STEMI) Rising Troponin (worse with inspiration)
↓ (NSTEMI/UA) ↓
Emergent Anti-ischemic Rx Pulmonary embolism?
PCI/thrombolysis + Cath within 24-72h Pericarditis?
Pneumonia?
└─────────────────────────────────────────────┘
Also consider: Aortic dissection (tearing, ± unequal BP)
PE (sudden dyspnea, hypoxemia)
Tension pneumothorax (absent breath sounds)
FLOWCHART B: Pathophysiology of Left-Sided Heart Failure
LV Systolic/Diastolic Dysfunction
↓
↑ LV EDP (end-diastolic pressure)
↓
↑ LA pressure → ↑ Pulmonary venous pressure
↓
↑ Pulmonary capillary hydrostatic pressure
↓
Fluid transudation into alveoli (pulmonary edema)
↓
Dyspnea, orthopnea, PND, crackles, frothy sputum
↓ ↓
Chronic: Forward failure:
Hemosiderin- ↓ CO → fatigue, ↓ exercise
laden macroph. tolerance, prerenal azotemia
("HF cells") cool extremities
Brown induration
of lungs
↓
↑ Pulmonary arterial pressure (reactive) → RV overload
↓
RIGHT-SIDED HEART FAILURE
(Peripheral edema, JVD, ascites, hepatomegaly)
TABLE: High-Yield Comparison - Major Cardiomyopathies
| Dilated | Hypertrophic | Restrictive | Arrhythmogenic (ARVC) |
|---|
| Chamber | All 4 dilated | LV hypertrophy ± LVOTO | All 4, normal size | RV fatty replacement |
| Wall | Thin, flabby | Thick, heavy | Rigid, non-compliant | Aneurysms, fibrofatty |
| EF | ↓↓ (<40%) | ↑ or normal | Normal or ↓ | ↓ RV function |
| Key gene | TTN, LMNA | MYH7, MYBP-C | TTR (amyloid), GAA (Pompe) | Desmoplakin, PKP2 |
| SCD risk | Moderate | HIGH (young athletes) | Moderate | HIGH (esp. athletes) |
| Treatment | GDMT + ICD | Myectomy/mavacamten/ICD | Treat cause | ICD, avoid sport |
TABLE: ECG Changes in Key Conditions
| Condition | ECG Findings |
|---|
| Hyperkalemia | Peaked T waves → wide QRS → sine wave → VF |
| Hypokalemia | Flat T waves, U waves, prolonged QU |
| Hypercalcemia | Short QT |
| Hypocalcemia | Prolonged QT |
| STEMI (anterior) | ST elevation V1-V4 (LAD) |
| STEMI (inferior) | ST elevation II, III, aVF (RCA) |
| STEMI (lateral) | ST elevation I, aVL, V5-V6 (LCx) |
| LBBB | Broad QRS + RSR' pattern V6; QS V1-V2 |
| RBBB | Broad QRS + RSR' ("rabbit ears") V1; S wave in V6 |
| Pericarditis | Diffuse saddle-back ST elevation + PR depression |
| PE | S1Q3T3; sinus tachycardia; RBBB; right heart strain |
| Digoxin | "Reverse tick" ST depression; short QT; AV block |
| WPW | Delta wave, short PR, broad QRS |
TABLE: Key Cardiac Enzymes, Biomarkers, and Clinical Use
| Marker | Rise | Peak | Sensitivity | Specificity | Use |
|---|
| Troponin I/T (hs) | 1-3 hr | 12-48 hr | Very high | High (cardiac specific) | Diagnosis + prognosis of MI |
| CK-MB | 4-8 hr | 18-24 hr | Moderate | Moderate | Reinfarction (returns to normal faster) |
| BNP/NT-proBNP | Hours | - | High for HF | Moderate | Diagnosis/prognosis of heart failure |
| Myoglobin | 1-2 hr | 4-8 hr | High (early) | Low | Early rule-out; not cardiac-specific |
| CRP (hs) | Days | - | Moderate | Low | Risk stratification for atherosclerosis |
| LDH | 24 hr | 3-6 days | Moderate | Low | Historical |
SUMMARY: HIGH-YIELD FACTS FOR EXAMINATIONS
-
Frank-Starling Law: The heart pumps whatever blood it receives; EDV is the main determinant of stroke volume under normal conditions.
-
Coronary Flow: 75% occurs in diastole; subendocardium is most vulnerable to ischemia.
-
Action Potential Plateau (Phase 2): Due to L-type Ca²⁺ channels; responsible for long refractory period → prevents cardiac tetanus; absent in nodal cells.
-
Irreversible MI injury: >20-30 minutes of ischemia; coagulative necrosis; troponin release.
-
MI Morphology Timeline: Wavy fibers (0.5-4 hr) → coagulative necrosis + neutrophils (1-3 days) → macrophages + granulation tissue (3-7 days) → scar (>2 months).
-
Most common cause of MI: Rupture of a non-critically stenosed atherosclerotic plaque (<50% stenosis) → acute thrombosis.
-
Vulnerable plaque: Thin fibrous cap, large lipid core, dense inflammation, high MMP activity.
-
HCM: Autosomal dominant; gain-of-function sarcomere mutations; myocardial disarray on biopsy; leading cause of SCD in young athletes.
-
DCM: Cytoskeletal protein mutations (TTN most common); dilated all 4 chambers; systolic dysfunction.
-
Most common cause of mitral stenosis: Rheumatic heart disease (Aschoff bodies; molecular mimicry).
-
Most common cause of mitral regurgitation (US): Mitral valve prolapse (myxomatous degeneration).
-
AAA: Infrarenal; male smokers >50; repair if ≥5.5 cm; classic: painless pulsatile abdominal mass; rupture = surgical emergency.
-
Aortic dissection Type A: Involves ascending aorta → surgical emergency; Type B → medical (BP control).
-
Cardiac tamponade: Beck's triad = hypotension + JVD + muffled heart sounds; pulsus paradoxus >10 mmHg.
-
Ventricular free wall rupture: Most common 3-7 days post-MI; hemopericardium → tamponade.
-
Septic shock hallmark: Refractory vasodilation via NO; cytokine storm; high or normal CO (distributive); DIC.
-
Virchow's Triad for Thrombosis: Endothelial injury + Stasis/turbulence + Hypercoagulability.
-
Kaposi Sarcoma: HHV-8 + HIV; spindle cells + slit-like vessels.
-
Cardiac pressure overload → concentric hypertrophy (sarcomeres added in parallel, thick wall); volume overload → eccentric hypertrophy (sarcomeres in series, cavity dilates).
-
BNP (B-type natriuretic peptide): Released by stretched ventricles; gold standard test for heart failure diagnosis; ↑ in both HFrEF and HFpEF.
REFERENCES
Guyton and Hall Textbook of Medical Physiology (14th Edition)
(ISBN: 9780443111013)
| Chapter | Topic | Block | Key Lines |
|---|
| Ch. 9 | Cardiac Muscle Physiology; Cardiac Cycle | Block 1 | 3570-3727 |
| Ch. 10 | Electrical Activity; SA Node; Conduction System | Block 2 | 341-480 |
| Ch. 11 | The Electrocardiogram | Block 2 | ~600-900 |
| Ch. 20 | Cardiac Output; Venous Return; Frank-Starling | Block 3 | 352-614 |
| Ch. 21 | Cardiac Output in Disease; Cardiogenic Shock | Block 3 | 533-570 |
| Ch. 17 | Local Control of Blood Flow; Autoregulation | Block 3 | - |
| Ch. 18 | Nervous Regulation of Circulation; Baroreceptors | Block 3 | - |
| Ch. 19 | Dominant Role of the Kidneys in Long-Term Regulation | Block 3 | - |
| Ch. 22 | Cardiac Failure | Block 3 | 1313-1500 |
| Ch. 23 | Coronary Circulation | Block 3 | 1017-1055 |
Robbins, Cotran & Kumar Pathologic Basis of Disease (10th Edition)
(ISBN: 9780443264528)
| Chapter | Topic | Block | Key Lines |
|---|
| Ch. 2 | Cellular Responses to Stress; Ischemic Injury | Block 1 | 1873-1885 |
| Ch. 4 | Hemodynamics; Edema; Thrombosis; Embolism; Shock | Block 2 | 296-756 |
| Ch. 11 | Blood Vessels: Atherosclerosis; Aneurysms; Vasculitis | Block 5 | 2764-3300 |
| Ch. 12 | Heart: IHD; Heart Failure; Cardiomyopathies; Valvular Disease | Block 6 | 430-2300 |
These notes integrate the physiological foundations from Guyton & Hall with the pathological mechanisms and clinical correlations from Robbins & Cotran, providing a complete framework for understanding the cardiovascular system from normal function to disease.